Westminster Health Forum

The future of the life sciences sector in the UK - funding, regulation and the impact of Brexit

Wednesday, 1st March 2017

Central London

THIS EVENT IS CPD CERTIFIED



This timely seminar focuses on the future of the life sciences industry in the UK.

It is scheduled as Government develops its proposed life science industrial strategy, and also comes in a context of uncertainty for the sector following the UK’s vote to leave the European Union.

Delegates will consider the work of the current UK EU Life Sciences Steering Group to manage the transition and how this presents challenges and opportunities for industry, with a particular focus on regulation - with priorities for the MHRA and the European Medicines Agency, as well as the next steps for research and development.

Further sessions focus on clinical trials and encouraging patient participation, in light of the launch of the European Commission’s new Clinical Trial Regulation in 2018; key issues for workforce development - including skills, recruitment and retention - as well as the next steps for encouraging innovation in the NHS after the publication of the Accelerated Access Review.


Guest of Honour

Dr Ian Hudson

Chief Executive, MHRA and Member (UK), Management Board, European Medicines Agency

Guest of Honour

Dr Ian Hudson

Chief Executive, MHRA and Member (UK), Management Board, European Medicines Agency

Chairs

Baroness Finlay of Llandaff

Chair of Trustees, National Council for Palliative Care and Chair, National Mental Capacity Forum

Daniel Zeichner MP

Vice Chair, All-Party Parliamentary Group for Life Sciences

Speakers

Professor Carole Longson

Director, Centre for Health Technology Evaluation, NICE

Nicole Mather

Director, Office for Life Sciences

Aisling Burnand

Chief Executive, Association of Medical Research Charities

Mike Thompson

Chief Executive Officer, ABPI

Joanna Woolf

Chief Executive, Cogent Skills

Professor Sir Robert Lechler

President, The Academy of Medical Sciences and Executive Director, King’s Health Partners

Dr John Williams

Managing Director, Birmingham Health Partners